Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022

Paul Choi Maintained (BBIO) at Strong Buy with Decreased Target to $19 on, May 24th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-19-on-may-24th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Paul Choi of Goldman Sachs, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Decreased Target from $24 to $19 on, May 24th, 2022.

Paul has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Paul's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Paul


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $27 on, Friday, May 6th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, March 16th, 2022
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $18 on, Friday, March 11th, 2022